Uber’s $1.15 Billion Aurora Gambit: Doubling Down or Cashing Out? Uber’s latest 8-K filing, dated May 20, 2025, has arrived, and it’s packed with intriguing...
Under Armour’s 2025 10-K: Restructuring, Retention, and a Revenue Roadblock Under Armour dropped their 2025 10-K on May 22nd, and it’s a mixed bag. Let’s...
Under Armour’s 2025 10-K: A Balancing Act Between Declining Revenue and Long-Term Growth Under Armour’s latest 10-K filing, released on May 22, 2025, offers a...
Tradeweb Markets Inc. Wraps Up 2025 Shareholder Meeting: Business as Usual? Tradeweb Markets Inc. (TW) recently filed an 8-K form on May 21, 2025, detailing...
Targa Resources Corp. Shareholders Give a Thumbs Up: Board Elections, Auditors, and Executive Pay Approved Targa Resources Corp. (TRGP) recently filed an 8-K on May...
The Oncology Institute (TOI) Shows Strong Growth and a Promising Future in Latest Investor Presentation The Oncology Institute, Inc. (TOI) filed an 8-K on May...
Tonix Pharmaceuticals Doses First Patient in Phase 2 Trial for TNX-102 SL: A Big Step Forward? Tonix Pharmaceuticals Holding Corp. (TNXP) filed an 8-K on...
Tandem Mobi Gets Green Light for Europe: Tandem Diabetes Care’s EU Expansion Plans Solidified Tandem Diabetes Care, Inc. (TNDM) recently filed an 8-K on May...
Thermo Fisher CEO Locked In: $60 Million Says He’ll Deliver Through 2030 Thermo Fisher Scientific Inc. (TMO) filed an intriguing 8-K on May 22, 2025,...
TJX Crushes Q1 Expectations: Discount Empire Strikes Back! TJX Companies Inc. dropped their 8-K filing on May 21, 2025, and we’re here to decode the...
